We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$32.7B
AUM Growth
+$8.12B
Cap. Flow
+$6.76B
Cap. Flow %
20.69%
Top 10 Hldgs %
11.63%
Holding
4,209
New
1,042
Increased
1,324
Reduced
1,059
Closed
704

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$271M
2
AAPL icon
Apple
AAPL
+$181M
3
MSFT icon
Microsoft
MSFT
+$171M
4
SBUX icon
Starbucks
SBUX
+$128M
5
AZO icon
AutoZone
AZO
+$113M

Sector Composition

Rank Sector Weight
1 Technology 11.74%
2 Consumer Discretionary 9.65%
3 Healthcare 6.66%
4 Financials 5.78%
5 Industrials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
3301
CALL
Bausch Health
BHC
$1.65B
$138K ﹤0.01%
+17,300
New +$128K
BRDG
3302
DELISTED
Bridge Investment Group
BRDG
$138K ﹤0.01%
12,191
-15,705
-56% -$160K
SCLX icon
3303
Scilex Holding
SCLX
$48.1M
$137K ﹤0.01%
703
+62
+10% +$17.1K
WHWK
3304
Whitehawk Therapeutics
WHWK
$183M
$136K ﹤0.01%
19,943
-838
-4% -$6.51K
BV icon
3305
BrightView Holdings
BV
$1.31B
$136K ﹤0.01%
18,951
-69,961
-79% -$442K
RDNW
3306
RideNow Group
RDNW
$247M
$135K ﹤0.01%
+10,889
New +$102K
CABA icon
3307
Cabaletta Bio
CABA
$439M
$135K ﹤0.01%
10,419
-46,645
-82% -$506K
TNGX icon
3308
Tango Therapeutics
TNGX
$4.34B
$134K ﹤0.01%
40,316
-52,422
-57% -$189K
AREC icon
3309
American Resources Corp
AREC
$186M
$132K ﹤0.01%
67,481
+29,113
+76% +$44.4K
PVBC
3310
DELISTED
Provident Bancorp
PVBC
$132K ﹤0.01%
+15,947
New +$120K
TROX icon
3311
Tronox
TROX
$995M
$131K ﹤0.01%
10,328
-14,594
-59% -$183K
MIST icon
3312
Milestone Pharmaceuticals
MIST
$144M
$130K ﹤0.01%
+45,694
New +$172K
AM icon
3313
PUT
Antero Midstream
AM
$10.8B
$130K ﹤0.01%
11,200
MBC icon
3314
MasterBrand
MBC
$1.09B
$128K ﹤0.01%
10,992
-147,604
-93% -$1.42M
HYFM icon
3315
Hydrofarm Holdings
HYFM
$3.13M
$127K ﹤0.01%
+16,274
New +$194K
BNED icon
3316
Barnes & Noble Education
BNED
$412M
$127K ﹤0.01%
1,005
+846
+532% +$118K
HCAT icon
3317
Health Catalyst
HCAT
$154M
$125K ﹤0.01%
+10,016
New +$119K
AVXL icon
3318
Anavex Life Sciences
AVXL
$222M
$124K ﹤0.01%
+15,193
New +$130K
FBP icon
3319
First Bancorp
FBP
$4.4B
$123K ﹤0.01%
10,067
-39,280
-80% -$457K
JMIA
3320
Jumia Technologies
JMIA
$726M
$123K ﹤0.01%
+35,888
New +$110K
TIL icon
3321
Instil Bio
TIL
$48.4M
$122K ﹤0.01%
11,114
+7,997
+257% +$97.7K
HUT
3322
Hut 8
HUT
$12.4B
$122K ﹤0.01%
7,414
-17,284
-70% -$177K
ORMP icon
3323
Oramed Pharmaceuticals
ORMP
$165M
$122K ﹤0.01%
+34,165
New +$110K
VYGR icon
3324
Voyager Therapeutics
VYGR
$187M
$122K ﹤0.01%
10,675
-32,526
-75% -$336K
LILAK icon
3325
Liberty Latin America Class C
LILAK
$1.5B
$120K ﹤0.01%
+15,351
New +$114K

Similar funds

Squarepoint's Q2 2023 Portfolio in Review

As of Q2 2023, Squarepoint held 4,209 positions worth $32.7B, up 33% from $24.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Squarepoint deployed $6.76B of net new capital in Q2 2023, opening 1,042 new positions and adding to 1,324 existing holdings. Its largest new stake was Home Depot: 275,512 shares worth $85.6M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Walmart Inc, an estimated $116M trimmed.

  • Squarepoint's largest Q2 2023 buy was Home Depot: 275,512 shares worth $85.6M.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $271M increase.
  • Squarepoint's biggest Q2 2023 reduction was Walmart Inc, cutting an estimated $116M.
  • Squarepoint fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2023, selling an estimated $208M.
  • Squarepoint's ten largest holdings make up 12% of its $32.7B portfolio in Q2 2023.
  • Squarepoint opened 1,042 new positions and closed 704 in Q2 2023.
  • Squarepoint's portfolio value rose 33% quarter-over-quarter to $32.7B.

Based on Squarepoint's 13F filing for Q2 2023, filed 14 Aug 2023.